Dynavax Technologies Corporation (DVAX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
2100 Powell Street
EmeryVille, CA 94608
United States of America (the)
Phone
510 848 5100
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
405
First IPO Date
February 19, 2004
| Name | Title | Pay | Year Born |
| Ryan Spencer | Chief Executive Officer & Director | 1.48M | 1979 |
| Kelly MacDonald | Senior Vice President & Chief Financial Officer | 733,501 | 1984 |
| John Slebir | Senior Vice President & General Counsel | 809,129 | 1965 |
| Robert Janssen | Chief Medical Officer and Senior Vice President of Clinical Development, Medical & Regulatory Affairs | 827,719 | 1954 |
| David F. Novack | Senior VP & COO | 965,313 | 1962 |
| Joseph Metzinger | Vice President & Chief Accounting Officer | 0 | 1984 |
| Paul Cox | Vice President of Investor Relations & Corporate Communications | 0 | N/A |
| Meg Smith | Senior Vice President of Commercial | 0 | N/A |
| Dong Yu | Senior Vice President of Research | 0 | N/A |
| Donn Casale | Senior Vice President & Chief Commercial Officer | 0 | N/A |
| Eric Frings | Vice President, Site Head & MD for Dynavax GmbH | 0 | N/A |
| Jeff Coon | Senior Vice President & Chief Human Resources Officer | 0 | 1963 |
Dynavax Technologies Corporation is a biopharmaceutical firm specializing in the development and market introduction of innovative vaccines, primarily operating in the United States. The company's lead product is HEPLISAV-B, a vaccine approved for adults 18 years and older in the U.S. and Europe, which offers protection against all identified subtypes of the hepatitis B virus. Additionally, Dynavax produces and distributes CpG 1018, the specific adjuvant ingredient used in HEPLISAV-B. Dynavax maintains several strategic alliances, including a collaboration agreement with Valneva Scotland Limited, an agreement with Serum Institute of India Pvt. Ltd., and a sublicense agreement with Merck, Sharp & Dohme Corp. The company, incorporated in 1996, was originally named Double Helix Corporation before adopting the name Dynavax Technologies Corporation in September of that year. Its corporate headquarters are situated in Emeryville, California.